[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572116":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":25,"responsibleParty":39,"collaborators":25,"id":41,"slug":25,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":25,"eligibilityCriteria":46,"healthyVolunteers":42,"sex":47,"minAge":48,"maxAge":25,"enrollmentInfo":49,"targetDuration":25,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":61,"overallStatus":67,"whyStopped":25,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":25},{"fullName":5,"class":6},"Saint-Joseph University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"sedation using propofol","PLACEBO_COMPARATOR","this group will include all patients who will receive propofol during the cardiac surgery and afterwards in the intensive care unit during the post operative phase",[13],"Drug: sedation using propofol",{"label":15,"type":16,"description":17,"interventionNames":18},"sedation using sevoflurane","ACTIVE_COMPARATOR","this group will include all patients who will receive sevoflurance druing the cardiac surgery and afterwards in the intensive care unit during the postoperative phase",[19],"Drug: sedation using sevoflurane",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","The different complications studied will be for example respiratory, neurologic and cardiac based on several clinical and biological parameters.",[9],null,{"type":22,"name":15,"description":27,"armGroupLabels":28,"otherNames":25},"The differents complications studied will be for example respiratory, neurologic and cardiac based on severl clinical and biological parameters.",[15],[30,35],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Sarah Harb, MD","CONTACT","+96171811646","sarah.harb@net.usj.edu.lb",{"name":36,"role":32,"phone":37,"phoneExt":25,"email":38},"Khalil Jabbour, MD","+96170009060","khaliljabbour@hotmail.com",{"type":40,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100572116",false,"NCT06729086","Propofol vs Sevoflurane in Cardiac Surgery","Propofol vs Sevoflurane in Cardiac Surgery: a Randomized Clinical Trial During the Peroperative and Postoperative Phase","Inclusion Criteria:\n\n* all patients above 18 yeras old that will undergo a cardiac surgery\n\nExclusion Criteria:\n\n* below 18 yeras old","ALL","18 Years",{"count":50,"type":51},100,"ESTIMATED","INTERVENTIONAL",[54],"NA","The hypothesis of our study: presence of a relationship between the type of anesthesia and complications after cardiac surgery. The aim is to assess the benefit of using intravenous or inhaled anesthesia on the patients\\' stay and its complications.",[57,58,59,60],"Cardiac Complications","Cardiac Surgery","Neurologic Complications","Respiratory Complications",[62,63,64,65,66],"propofol vs sevoflurane in cardiac surgery","peroperative","postoperative","randomized clinical trial","complications","NOT_YET_RECRUITING","2024-12-09",{"date":70,"type":71},"2024-12-11","ACTUAL",{"date":73,"type":51},"2025-01-04",{"date":75,"type":51},"2025-05-31",{"name":5,"class":6}]